Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users

doi:10.5498/wjp.v12.i7.944

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3043)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

175

WORD

HTML

1109

Figures (1-4)

111

Tables (1-6)

103

Sum=1552

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

178

Download

526

Sum=704

Publishing Process of This Article

Item

Count

Browse

249

Download

538

Sum=787

Jul 19, 2022 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Psychiatry. Jul 19, 2022; 12(7): 944-957
Published online Jul 19, 2022. doi: 10.5498/wjp.v12.i7.944

Table 5 Number of comorbid diagnoses

	MA group, n = 54	OS group, n = 55	P
Depression	11	15	0.40
Anxiety disorder	5	0	0.03
Eating disorder	0	2	0.49
Obsessive-compulsive disorder	0	0	-
Posttraumatic stress disorder	15	12	0.47
Personality disorder	11	11	0.96
ADHD	6	7	0.80
Psychotic disorder	3	10	0.042
Somatoform disorder	18	0	< 0.001

Data displays number of participants diagnosed with the respective comorbidity. ADHD: Attention deficit and hyperactivity disorder; MA: Methamphetamine; OS: Other substances.

Citation: Behle N, Kamp F, Proebstl L, Hager L, Riebschläger M, Schacht-Jablonowsky M, Hamdorf W, Neumann S, Krause D, Manz K, Franke AG, Koller G, Soyka M. Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users. World J Psychiatry 2022; 12(7): 944-957
URL: https://www.wjgnet.com/2220-3206/full/v12/i7/944.htm
DOI: https://dx.doi.org/10.5498/wjp.v12.i7.944